Core Scientific, Inc./tx Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 15.57%43.87%1.31%24.57%23.71%
EBT Margin -20.24%11.58%-337.87%-48.93%-257.34%
EBIT Margin -10.49%24.15%-329.46%1.78%-3.76%
EBITDA Margin -10.49%24.15%-329.46%1.78%-3.76%
Operating Margin -10.49%24.15%-329.46%1.78%-3.76%
Net Margin -37.61%8.69%-335.20%-49.07%-257.51%
FCF Margin -43.62%-10.42%-27.92%9.74%-10.20%
Efficiency
Assets Average 1,219.44M1,623.28M759.92M1,155.49M
Equity Average 670.61M465.93M-503.14M-708.56M
Invested Capital 0.01M1,341.21M-409.35M-541.42M-818.51M
Asset Utilization Ratio 0.450.390.660.44
Leverage & Solvency
Debt to Equity 0.49-1.15-1.31
Debt Ratio 0.270.960.67
Equity Ratio 0.970.55-0.51-0.84-0.51
Valuation
Enterprise Value -131.68M-52.24M-69.71M3,086.52M
Market Capitalization 3,923.50M
Return Ratios
Return on Sales -0.20%0.09%-3.35%-0.49%-2.58%
Return on Capital Employed 0.15%-1.47%0.03%-0.02%
Return on Invested Capital 0.15%-4.49%
Return on Assets 0.04%-1.32%-0.32%-1.14%
Return on Equity 0.07%-4.61%0.49%1.86%